The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> April 18, 2013

Interview with the President and CEO: Innovus Pharmaceuticals, Inc. (INNV)

Damaj, Bassam
Dr. Bassam Damaj, Ph.D., was appointed to serve as President and CEO on January 22, 2013. Before joining Innovus Pharmaceuticals, Inc., Dr. Damaj served as President and Chief Executive Officer of Apricus Biosciences (APRI) from December 2009 until November 2012. At Apricus Bio, Dr. Damaj was responsible for the approval of its lead drug, Vitaros, a treatment for erectile dysfunction. Dr. Damaj also signed multi-million-dollar partnerships between Apricus Bio and leading pharmaceutical companies, such as Abbott, Novartis-Sandoz and Takeda. At Apricus Bio, he successfully designed and executed on a business plan that resurrected the company, its technology platform and its products, and grew the company to more than $100 million in market capitalization. Prior to Apricus Bio, Dr. Damaj was a Co-Founder of Bio-Quant, Inc., and served as the Chief Executive Officer and Chief Scientific Officer, and a Director of Bio-Quantís board of directors from its inception in June 2000 until its acquisition by Apricus Biosciences in June 2009. In addition, Dr. Damaj was the Founder, Chairman, President and Chief Executive Officer of R&D Healthcare, and the Co-Founder of Celltek Biotechnologies. He also served as a Director at CreAgri, Inc., and was member of the Scientific Advisory Board of MicroIslet, Inc. Dr. Damaj is the author of the Immunological Reagents and Solutions reference book, the inventor of many patents and author of numerous peer reviewed scientific publications. In 2003, Dr. Damaj won a U.S. Congressional award for the Anthrax Multiplex Diagnostic Test. He holds a Ph.D. degree in immunology/microbiology from Laval University, and he completed a postdoctoral fellowship in molecular oncology from McGill University School of Medicine. Profile
TWST: Please provide an overview of Innovus Pharmaceuticals and its operations.

Dr. Damaj: Innovus Pharmaceuticals is headquartered in La Jolla, California. We’re a small,

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy